Results

Total Results: 801 records

Showing results for "described".

81. Update on Methods: Insufficient Evidence | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/update-methods-insufficient-evidence
    March 04, 2021 - resulted in a decision to transform what had been called an "I recommendation" into an "I statement," as described … The 4 information groups came to be described as "domains," a term that connotes hierarchical ranking

82. Final Research Plan: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/brca-related-cancer-risk-assessment-genetic-counseling-testing
    April 11, 2024 - . ‡ Pretest genetic counseling, scope of services, and appropriate providers are described in the Research

83. Screening for Speech and Language Delay in Preschool Children: Systematic Evidence Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/cmJ4Bm9BysHuBX2Wy8MQbc
    December 07, 2005 - The performance characteristics of evaluation techniques that take ≤ 10 minutes to administer were described … Several types of speech and language delay and disorders have been described,8 although terminology … Search terms were determined by investigators and a research librarian and are described elsewhere.33 … be administered in a primary care setting by nonspecialists are most relevant to screening and are described … length utterances, used by 6 studies.73, 75, 77, 80, 85 Studies rated good or fair quality are described

84. Archived: Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-adults-with-high-risk-of-cvd-august-2014
    August 26, 2014 - The USPSTF previously described the challenges of developing behavioral counseling recommendations that … These interventions are described in further detail because they can be provided by an appropriately … Potential Conflicts of Interest: Authors followed the policy regarding conflicts of interest described

85. Recommendation: Ovarian Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening
    February 13, 2018 - The CA-125 ROCA screening intervention group was described as multimodal screening in the trial publications … Screening The USPSTF reviewed evidence on harms of screening for ovarian cancer from the 3 studies described … Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org

86. Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/5P_7f2rbEquA-ZR-fJJfHK
    April 27, 2021 - Other organizations provide in- formation on validated devices, which is described in the Recom- mendations … evidence on optimal screening intervals for hypertension remains limited; however, the screening intervals described … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

87. Recommendation: Hypertension in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-in-adults-screening
    April 27, 2021 - Other organizations provide information on validated devices, which is described in the Recommendations … evidence on optimal screening intervals for hypertension remains limited; however, the screening intervals described … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

88. Screening for Visual Impairment in Children Ages 1–5 Years: Update for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/r_MgZHrtyHRn7rZoCPS6MT
    February 01, 2011 - of age and included in analyses; 782 children examined in “nonscreening” city; loss to follow-up not described … amblyogenic risk factors: 45% (23/51) Pediatric ophthalmology clinic, United States, screener not described … � 300; amblyogenic risk factors: 56% (168/300) Pediatric ophthalmology clinic, China, screener not described … at Caribbean-American preschool and children of indigent Spanish-speaking farmworkers), screener not described … 387); refractive error: 55% (211/387) Pediatric ophthalmology clinic, United States, screener not described

89. Final Research Plan: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/genital-herpes-serologic-screening
    December 02, 2021 - The limited systematic review update for this topic will be conducted using synthesis procedures described

90. Tagauj5Qoarfv3M8Fapbon (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TAgAUJ5QoaRfV3M8fApBoN
    June 03, 2019 - METHODS The analytic framework, literature search, and data ex- traction are described in detail in … Allocation con- cealment not described Allocation con- cealment not described Allocation conceal- … Their methods were poorly described, which limits precision in critical ap- praisal. … As described below, we used a systematic approach to assess the flaws of the trials in each of these … Postrandomization exclusions were poorly described in sev- eral of the mammography trials and could have

91. Archived: Evidence Summary: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
    January 10, 2017 - Evidence From Trials One RCT, described in 7 publications, 8-13 , 15 randomized 5453 women in Hungary … Evidence From Cohort Studies At the conclusion of the RCT described above, no additional RCT was considered … Both of the risks of bias described above (case ascertainment and recall) will reduce the differences … third meta-analysis, 35 consisting of a subset of the primary studies in the other 2 meta-analyses described … above, 26 , 34 , 35 is not described in this table.

92. Recommendation: Breastfeeding: Primary Care Behavioral Counseling Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breastfeeding-primary-care-interventions
    April 11, 2025 - Rates of breastfeeding are described in terms of initiation (starting breastfeeding or introducing … intervention was delivered (office, hospital, home, video, telephone, or text). 29 , 30 Few of the studies described … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

93. Primary Care Behavioral Counseling Interventions to Support Breastfeeding: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/r77BgfGVeBPRDME-DpBvFk
    April 08, 2025 - Rates of breastfeeding are described in terms of initiation (starting breastfeeding or introducing breast … intervention was de- livered (office, hospital, home, video, telephone, or text).29,30 Few of the studies described … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

94. Screening for Intimate Partner Violence and for Caregiver Abuse of Older and Vulnerable Adults: An Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/RrE4_peSk5zVH3cCf77at3
    June 24, 2025 - was made to the hospital social worker or community specialist. c Estimate based on a questionnaire described … 6 in the Supplement).42 Benefit of Interventions Among Nonpregnant Populations Six RCTs (n = 5712, described … g Usual care described as 2 violence screening questions on clinic intake form and usual clinic protocol … h Usual care described as standard IPV question on intake sheet and referral if IPV was discussed. … Some existing studies have described the development of screening tools for use among transgender populations

95. Draft Recommendation: Breastfeeding: Primary Care Behavioral Counseling Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/breastfeeding-interventions
    October 22, 2024 - Rates of breastfeeding are described in terms of initiation (starting breastfeeding or introducing … intervention was delivered (office, hospital, home, video, telephone, or text). 1 Few of the studies described

96. Cancer Older Adults (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/cancer_older_adults.pdf
    September 28, 2012 - The risks of false positive screening tests have been well described elsewhere,17 and range from emotional … However, these risks have rarely been specifically described for older adults, so we can only speculate … screening, history of cervical cancer) this could be important, but test character- istics are so poorly described

97. Draft Research Plan: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/sexually-transmitted-infections
    January 16, 2025 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Draft Research Plan Sexually Transmitted Infections: Behavioral Counseling January 16, 2025 Recommendations made by the USPSTF are independent of the U.S. gover…

98. Archived: Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
    October 07, 2011 - Only 2 studies 33 , 40 clearly described the control group intervention ( Appendix Table 2 ). … trials included failure to describe adequate randomization or allocation concealment methods, poorly described … The largest study, a previously described analysis of SEER data, found radiation therapy to be associated … A large Swedish cohort study (also described earlier) found radiation therapy to be associated with decreased … (due to repeated biopsies or subsequent interventions) than watchful waiting, and studies with well-described

99. Archived: Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening-september-2016
    September 06, 2016 - 98 ; and 1 compared rifapentine plus isoniazid with isoniazid alone (n = 6886). 96 The IUAT trial (described … 116) compared 4 months of rifampin with 9 months of isoniazid. 94 A later study by the same authors (described … The PREVENT TB trial (described above) reported rates of grade 3 hepatotoxicity of 4.9% in the rifapentine … number of included studies with large sample sizes and precise estimates, a phenomenon that has been described … Isoniazid vs placebo: Harm ascertainment techniques not well described; very few deaths due to hepatotoxicity

100. Behavioral Counseling Research and Evidence-Based Practice Recommendations: U.S. Preventive Services Task Force Perspectives | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/behavioral-counseling-research-and-evidence-based-practice-recommendations-us-preventive-services-task-force-perspectives
     March 01, 2014 - the potential of modifying health behaviors for prevention as early as 1996 11 and has previously described … the characteristics of the study population relating to symptoms or risk status are often not clearly described